Therefore, these reports indicate that IRES are good targets for AD treatment due to the reason that the internal initiation of translation of the APP and tau mRNAs is an important mode for the synthesis of both APP and tau, a mechanism which is controlled by conditions that also contribute to AD pathology [59,60]. This evidence concerns the gene APP and Alzheimer disease.